All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0379 | Human anti-esxH T cell receptor (TCR098), pCDTCR1 | Mycobacterium tuberculosis | TCR098 | Human | MSQIMYNYPAMLGHA | HLA-DRB3*03:01 | Lentiviral vector | |
TCR-YC0380 | Human anti-esxH T cell receptor (TCR099), pCDTCR1 | Mycobacterium tuberculosis | TCR099 | Human | MSQIMYNYPAMRAHA | HLA-DRB3*03:01 | Lentiviral vector | |
TCR-YC0381 | Mouse anti-esxH T cell receptor (TCR3), pCDTCR1 | Mycobacterium tuberculosis | TCR3 | Mouse | IMYNYPAM | H2-Kᵇ | Lentiviral vector | |
TCR-ZP206 | Human anti-esxH T cell receptor (), pCDTCR1 | Mycobacterium tuberculosis | Human | AAVVRFQEAANKQK | HLA-DR | Lentiviral vector | ||
TCR-ZP207 | Mouse anti-esxH T cell receptor (P25), pCDTCR1 | Mycobacterium tuberculosis | P25 | Mouse | IMYNYPAM | H-2Kb | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION